ArticleFrontiers in medicine2026
Pharmacist-led medication therapy management improving medication adherence in a patient with type 2 diabetes: case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Poor medication adherence is a major challenge in healthcare for patients with type 2 diabetes mellitus (T2DM), particularly those with long disease duration, multiple comorbidities, and complex therapeutic regimens. This case report describes the application of pharmacist-led MTM (medication therapy management) in a patient with T2DM presenting complex therapeutic regimens and poor adherence. Patients and methods: A 76-year-old female with a 30-year history of T2DM complicated by diabetic peripheral neuropathy, hypertension, hyperlipidemia, hepatic steatosis, coronary atherosclerosis, and severe osteoporosis. The patient presented with poor glycemic control and severe medication nonadherence, which was characterized by frequent missed doses, irregular glucose monitoring, and forgotten weekly semaglutide injections. A clinical pharmacist conducted comprehensive MTM, including a full medication review, patient education, systematic medication and blood glucose monitoring, development of an optimized treatment plan in collaboration with the medical team, and ongoing follow-up. Results: After 3 months, glycemic control improved significantly, with fasting blood glucose at 7.6 mmol/L, postprandial glucose at 10.2 mmol/L, and glycated hemoglobin (HbA1c) at 7.3%. The Medication Adherence Report Scale-5 (MARS-5) score increased from 8 to 21, and no severe hypoglycemic events or other adverse drug reactions occurred during hospitalization or follow-up. Conclusion: Improvements in medication adherence and clinical outcomes were achieved following comprehensive pharmacist-led medication therapy management integrated with individualized clinical management in this case.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.